Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Nature Communications|May 13, 2026
Personalized machine learning-guided radiation dose escalation in newly diagnosed glioblastoma: prospective pilot studyHamed Akbari, Suyash Mohan, Fang Liu, et al.
Cancer Cell|July 11, 2018
Epidermal Growth Factor Receptor Extracellular Domain Mutations in Glioblastoma Present Opportunities for Clinical Imaging and Therapeutic DevelopmentZev A Binder, Amy Haseley Thorne, Spyridon Bakas, et al.
Biorxiv : the Preprint Server for Biology|April 22, 2024
All-trans retinoic acid induces durable tumor immunity in IDH-mutant gliomas by rescuing transcriptional repression of the CRBP1-retinoic acid axisAparna Rao, Xiaoran Zhang, Anthony R Cillo, et al.
Scientific Data|July 29, 2022
The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomicsSpyridon Bakas, Chiharu Sako, Hamed Akbari, et al.
Nature Medicine|March 14, 2024
Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim resultsStephen J Bagley, Meghan Logun, Joseph A Fraietta, et al.
Neuro-Oncology|October 6, 2025
Intracranial metastases from solid tumors: Call to Action and Consensus from the Society for Neuro-Oncology and American Society of Clinical Oncology CollaborativeAkanksha Sharma, Lucy Boyce Kennedy, Amanda E D Van Swearingen, et al.
Nature Cancer|January 12, 2024
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trialStephen J Bagley, Zev A Binder, Lamia Lamrani, et al.
Nature Medicine|June 1, 2025
Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trialStephen J Bagley, Arati S Desai, Joseph A Fraietta, et al.
Neuro-Oncology|March 22, 2025
A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastomaPatrick Y Wen, Andrea Manzanera, Caroline Duault, et al.
Cell|June 15, 2026
The critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBMNelson F Freeburg, Daniel Chafamo, Gayathri Konanur Gopikrishna, et al.
Pageof 9